Cargando…

Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life

The aim of the study was to investigate the mechanisms leading to immunization through the use of a multicomponent bacterial immunomodulator and to find out the relationship between the TLR 4 receptor with selected parameters of innate immunity and to acquire immunity. The study was conducted on 18...

Descripción completa

Detalles Bibliográficos
Autores principales: Anna, Migdał, Łukasz, Migdał, Adam, Okólski, Chełmońska-Soyta, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499974/
https://www.ncbi.nlm.nih.gov/pubmed/36138050
http://dx.doi.org/10.1038/s41598-022-17532-1
_version_ 1784795114363682816
author Anna, Migdał
Łukasz, Migdał
Adam, Okólski
Chełmońska-Soyta, Anna
author_facet Anna, Migdał
Łukasz, Migdał
Adam, Okólski
Chełmońska-Soyta, Anna
author_sort Anna, Migdał
collection PubMed
description The aim of the study was to investigate the mechanisms leading to immunization through the use of a multicomponent bacterial immunomodulator and to find out the relationship between the TLR 4 receptor with selected parameters of innate immunity and to acquire immunity. The study was conducted on 18 Polish Pony Horses foals divided into two study groups: control (n = 9) and experimental (n = 9). Foals from the experimental group received intramuscular duplicate injection of 5 ml of multi-component bacterial immunomodular at 35 and 40 days of age. RNA isolated from venous blood was used to evaluate the expression of TLR4 genes using RT-PCR. Concentration of Il-6, IL-10, IgM and IgG2 was determined by the ELISA method in blood plasma. Immunostimulation had a significant impact on the level of genes expression for TLR4 expression and IL-6 concentration. No effect of stimulation on IgM and IgG2 concentrations was found. The expression of TLR4 genes as well as the levels of interleukins could be modulated by stimulation with a pharmacological agent multi-component bacterial immunomodulator. The experiment demonstrated a strong positive correlation between TLR4 gene expression and IL-6 concentration and between TLR4 gene expression and IgM concentration.
format Online
Article
Text
id pubmed-9499974
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-94999742022-09-24 Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life Anna, Migdał Łukasz, Migdał Adam, Okólski Chełmońska-Soyta, Anna Sci Rep Article The aim of the study was to investigate the mechanisms leading to immunization through the use of a multicomponent bacterial immunomodulator and to find out the relationship between the TLR 4 receptor with selected parameters of innate immunity and to acquire immunity. The study was conducted on 18 Polish Pony Horses foals divided into two study groups: control (n = 9) and experimental (n = 9). Foals from the experimental group received intramuscular duplicate injection of 5 ml of multi-component bacterial immunomodular at 35 and 40 days of age. RNA isolated from venous blood was used to evaluate the expression of TLR4 genes using RT-PCR. Concentration of Il-6, IL-10, IgM and IgG2 was determined by the ELISA method in blood plasma. Immunostimulation had a significant impact on the level of genes expression for TLR4 expression and IL-6 concentration. No effect of stimulation on IgM and IgG2 concentrations was found. The expression of TLR4 genes as well as the levels of interleukins could be modulated by stimulation with a pharmacological agent multi-component bacterial immunomodulator. The experiment demonstrated a strong positive correlation between TLR4 gene expression and IL-6 concentration and between TLR4 gene expression and IgM concentration. Nature Publishing Group UK 2022-09-22 /pmc/articles/PMC9499974/ /pubmed/36138050 http://dx.doi.org/10.1038/s41598-022-17532-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Anna, Migdał
Łukasz, Migdał
Adam, Okólski
Chełmońska-Soyta, Anna
Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
title Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
title_full Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
title_fullStr Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
title_full_unstemmed Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
title_short Effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
title_sort effectiveness of immunization with multi-component bacterial immunomodulator in foals at 35th day of life
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499974/
https://www.ncbi.nlm.nih.gov/pubmed/36138050
http://dx.doi.org/10.1038/s41598-022-17532-1
work_keys_str_mv AT annamigdał effectivenessofimmunizationwithmulticomponentbacterialimmunomodulatorinfoalsat35thdayoflife
AT łukaszmigdał effectivenessofimmunizationwithmulticomponentbacterialimmunomodulatorinfoalsat35thdayoflife
AT adamokolski effectivenessofimmunizationwithmulticomponentbacterialimmunomodulatorinfoalsat35thdayoflife
AT chełmonskasoytaanna effectivenessofimmunizationwithmulticomponentbacterialimmunomodulatorinfoalsat35thdayoflife